Related Experiment Video
Updated: Mar 9, 2026
05:39
Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
964
Canine spinal cord glioma
Daniel R Rissi1,2, Renee Barber1,2, Annabelle Burnum1,2
1Department of Pathology and Athens Veterinary Diagnostic Laboratory (Rissi, Burnum) and Neurology and Neurosurgery Service, University of Georgia College of Veterinary Medicine, Athens, GA (Barber).
Summary
Canine spinal gliomas are rare tumors. This study details 7 cases, revealing progressive clinical signs and the need for advanced diagnostics like immunohistochemistry for accurate diagnosis.
Area of Science:
- Veterinary Neurology
- Canine Pathology
- Neuro-oncology
Background:
- Spinal cord gliomas are infrequently documented in veterinary literature.
- Understanding their clinicopathologic features is crucial for diagnosis and management in dogs.
Observation:
- Seven canine spinal glioma cases were analyzed, with affected dogs presenting at a median age of 7.2 years.
- Clinical signs were progressive, often indicating multiple spinal cord locations, and diagnostic imaging revealed characteristic T2-weighted hyperintense lesions.
- All cases were diagnosed via histopathology and immunohistochemistry, identifying oligodendroglioma, gliomatosis cerebri, and astrocytoma.
Findings:
- The study defines the clinicopathologic and diagnostic features of canine spinal gliomas.
- Immunohistochemistry, specifically markers like glial fibrillary acidic protein and Ki-67, is essential for confirming diagnoses.
- Common diagnoses included oligodendroglioma (4 cases) and gliomatosis cerebri (2 cases).
Implications:
- This research enhances the understanding of canine spinal gliomas, aiding in earlier and more accurate diagnosis.
- It underscores the importance of integrating advanced diagnostic techniques for definitive tumor classification.
- The findings contribute to improved diagnostic protocols for central nervous system tumors in veterinary medicine.
